<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Helderman RFCPA</submitter><funding>KWF Kankerbestrijding</funding><pagination>E1775</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7464333</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(8)</volume><pubmed_abstract>Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment with curative intent for peritoneal metastasis of colorectal cancer (CRC). Currently, there is no standardized HIPEC protocol: choice of drug, perfusate temperature, and duration of treatment vary per institute. We investigated the temperature-dependent effectiveness of drugs often used in HIPEC.&lt;h4>Methods&lt;/h4>The effect of temperature on drug uptake, DNA damage, apoptosis, cell cycle distribution, and cell growth were assessed using the temperature-dependent IC50 and Thermal Enhancement Ratio (TER) values of the chemotherapeutic drugs cisplatin, oxaliplatin, carboplatin, mitomycin-C (MMC), and 5-fluorouracil (5-FU) on 2D and 3D CRC cell cultures at clinically relevant hyperthermic con</pubmed_abstract><journal>Cells</journal><pubmed_title>The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.</pubmed_title><pmcid>PMC7464333</pmcid><funding_grant_id>UVA grant number 10595</funding_grant_id><pubmed_authors>Loke DR</pubmed_authors><pubmed_authors>Garcia Vallejo JJ</pubmed_authors><pubmed_authors>Franken NAP</pubmed_authors><pubmed_authors>Verhoeff J</pubmed_authors><pubmed_authors>Boon M</pubmed_authors><pubmed_authors>Kok HP</pubmed_authors><pubmed_authors>Helderman RFCPA</pubmed_authors><pubmed_authors>Rodermond HM</pubmed_authors><pubmed_authors>Oei AL</pubmed_authors><pubmed_authors>van Kesteren S</pubmed_authors><pubmed_authors>Crezee J</pubmed_authors><pubmed_authors>van Bochove GGW</pubmed_authors><pubmed_authors>Tanis PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.</name><description>Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment with curative intent for peritoneal metastasis of colorectal cancer (CRC). Currently, there is no standardized HIPEC protocol: choice of drug, perfusate temperature, and duration of treatment vary per institute. We investigated the temperature-dependent effectiveness of drugs often used in HIPEC.&lt;h4>Methods&lt;/h4>The effect of temperature on drug uptake, DNA damage, apoptosis, cell cycle distribution, and cell growth were assessed using the temperature-dependent IC50 and Thermal Enhancement Ratio (TER) values of the chemotherapeutic drugs cisplatin, oxaliplatin, carboplatin, mitomycin-C (MMC), and 5-fluorouracil (5-FU) on 2D and 3D CRC cell cultures at clinically relevant hyperthermic con</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2026-05-07T16:03:52.728Z</modification><creation>2020-09-10T07:16:11Z</creation></dates><accession>S-EPMC7464333</accession><cross_references><pubmed>32722384</pubmed><doi>10.3390/cells9081775</doi></cross_references></HashMap>